- Are the best antiretrovirals being used in Africa?Laurence John
Infectious Disease Institute, Mulago Hospital Complex, Kampala, Uganda
J HIV Ther 11:11-5. 2006
- HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activationAlan Steel
Department of Immunology, Imperial College, Chelsea and Westminster Hospital, London
Antivir Ther 12:971-5. 2007..To determine if the expression of CD38 on CD8+ T-cells could be used as a marker of viral replication <50 copies/ml in peripheral blood...
- Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteriaDavid Meya
Infectious Diseases Institute, Makerere University, Kampala, Uganda
J Int AIDS Soc 12:3. 2009..abstract:..
- Worsening and unmasking of tuberculosis in HIV-1 infected patients after initiating highly active anti-retroviral therapy in UgandaJoshua Baalwa
Makerere University, Infectious Diseases Institute, Kampala, Uganda
Afr Health Sci 8:190-5. 2008..To determine the proportion of patients developing active tuberculosis (TB) versus that of patients who experience worsening of TB, after initiating highly active anti retroviral therapy (HAART)...
- Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicityBarbara Castelnuovo
Infectious Diseases Institute, Kampala, Uganda
J Int Assoc Physicians AIDS Care (Chic) 8:52-9. 2009..To evaluate the safety and virological response to lopinavir/ritonavir containing second-line therapy after failing a first line nonnucleoside reverse transcriptase inhibitor (NNRTI) based regimen...
- Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in UgandaLaura Waters
St Stephens AIDS Trust, Chelsea and Westminster Hospital, London, UK
J Acquir Immune Defic Syndr 46:590-3. 2007..We investigated filter paper transfer (FPT) of whole blood and plasma as an alternative to standard plasma-based assays for virologic monitoring in Uganda...
- Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settingsGraeme Meintjes
Institute of Infectious Diseases and Molecular Medicine and Department of Medicine, University of Cape Town, Cape Town, South Africa
Lancet Infect Dis 8:516-23. 2008..It is envisaged that these definitions could be used by clinicians and researchers in a variety of settings to promote standardisation and comparability of data...
- When to switch for antiretroviral treatment failure in resource-limited settings?Marc Vekemans
Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium
AIDS 21:1205-6. 2007
- Response to 'Does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy?' AIDS, 22 July 2005Laurence John
AIDS 19:2049-50. 2005
- The outbreak and control of Ebola viral haemorrhagic fever in a Ugandan medical schoolMedard Bitekyerezo
Mbarara University Teaching Hospital, Uganda
Trop Doct 32:10-5. 2002..The implications for similar institutions in East Africa are discussed...